Skip to content

Lung Cancer Health Center

Font Size

Lung Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Overview

Separate PDQ summaries on Lung Cancer Prevention, Small Cell Lung Cancer Treatment, Non-Small Cell Lung Cancer Treatment, and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Evidence of Benefit Associated With Screening

Recommended Related to Lung Cancer

Cellular Classification of Malignant Mesothelioma

Histologically, these tumors are composed of fibrous or epithelial elements or both. The epithelial form occasionally causes confusion with peripheral anaplastic lungcarcinomas or metastatic carcinomas. Attempts at diagnosis by cytology or needle biopsy of the pleura are often unsuccessful. It can be especially difficult to differentiate mesothelioma from adenocarcinoma on small tissue specimens. Thoracoscopy can be valuable in obtaining adequate tissue specimens for diagnostic purposes.[1] Examination...

Read the Cellular Classification of Malignant Mesothelioma article > >

Screening by low-dose helical computed tomography

Benefits

There is evidence that screening persons aged 55 to 74 years who have cigarette smoking histories of 30 or more pack-years and who, if they are former smokers, have quit within the last 15 years reduces lung cancer mortality by 20% and all-cause mortality by 6.7%.

Magnitude of Effect: 20% relative reduction in lung cancer–specific mortality.

  • Study Design: Evidence obtained from a randomized controlled trial.
  • Internal Validity: Good.
  • Consistency: Not applicable—one randomized trial to date.
  • External Validity: Fair.

Harms

Based on solid evidence, screening would lead to false-positive tests in approximately one-quarter of those screened. Most abnormalities would be monitored radiographically. However, persons with false-positive screens and overdiagnosed cancers would be exposed to unnecessary invasive diagnostic procedures and treatments. Because of comorbidities among the heaviest smokers and those who have smoked for long periods of time, complications associated with invasive diagnostic procedures and therapy may be more frequent in these groups.

Magnitude of Effect: Positive. Magnitude is a 20% relative reduction in lung cancer–specific mortality and a 6.7% reduction in overall mortality.

  • Study Design: Evidence obtained from a randomized controlled trial.
  • Internal Validity: Good.
  • Consistency: Good.
  • External Validity: Fair.

Evidence of No Benefit Associated With Screening

Screening by chest x-ray and/or sputum cytology

Benefits

Based on solid evidence, screening with chest x-ray and/or sputum cytology does not reduce mortality from lung cancer in the general population or in ever-smokers.

Magnitude of Effect: No evidence of effect.

  • Study Design: Randomized controlled trials.
  • Internal Validity: Good.
  • Consistency: Good.
  • External Validity: Good.

Harms

False positive exams

Based on solid evidence, at least 95% of all positive chest x-ray screening exams (but not all) do not result in a lung cancer diagnosis. False-positive exams result in unnecessary invasive diagnostic procedures.

  • Study Design: Randomized controlled trials.
  • Internal Validity: Good.
  • Consistency: Good.
  • External Validity: Good.
    1|2
    Next Article:

    Today on WebMD

    Broken cigarette
    Do you know the myths from the facts?
    man with a doctor
    Our health check will steer you in the right direction.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    15 Cancer Symptoms Men Ignore
    FEATURE
    Lung Cancer Risks Myths and Facts
    SLIDESHOW
     
    cancer fighting foods
    SLIDESHOW
    Improving Lung Cancer Survival Targeted Therapy
    VIDEO
     
    Lung Cancer Surprising Differences Between Sexes
    VIDEO
    Pets Improve Your Health
    SLIDESHOW
     
    Vitamin D
    SLIDESHOW
    Lung Cancer Surgery Options
    VIDEO
     

    WebMD Special Sections